Multilayer stents in the treatment of thoraco-abdominal residual type B dissection

Abstract

Multilayer stents are already being used for the treatment of peripheral aneurysms. In France, they are currently under evaluation in the treatment of thoraco-abdominal aneurysms. We have used multilayer stents to treat aneurysmal evolution of thoraco-abdominal residual type B dissection. Third month computed tomography (CT)-scan showed a false channel no longer patent. Multilayer stents are promising but it is too soon to draw conclusions on the use of this device in the treatment of patent false channels.

Assessment of Biocompatibility of the Multilayer Flow Modulator with Differing Thread Designs

“…Clinical results have been published on the MFM device used to treat aortic, peripheral and visceral aneurysms [7][8][9][15][16][17]. However, there is paucity of long-term data in relation to this new device, with current literature reporting relatively short follow up results [15][16][17].…”

“…However, there is paucity of long-term data in relation to this new device, with current literature reporting relatively short follow up results [15][16][17]. When conducted strictly in accordance with the device instructions for use (IFU), deployment of the MFM has produced consistently positive outcomes in aortic pathologies including TAAA and aortic type B dissections [7][8][9]15]. The preliminary results of this study compare favorably with the current clinical findings, given the evidence for endothelialization and integration of the device into the artery.…”

“…The device has since been implanted in numerous patients on compassionate grounds [4][5][6][7][8]. The MFM has been used successfully to treat renal artery aneurysms [4,5], visceral artery aneurysms [6], and aortic pathologies including TAAA and aortic type B dissections [3,[7][8][9].…”

A Pilot Study of the Intracranial Multilayer Flow Modulator as a New Disruptive Technology in the Treatment of Cerebral Aneurysms

“…To date, the MFM has already been successfully translated to human research (Henry et al 2008;Polydorou et al 2010;Chocron et al 2011;Ferrero et al 2011;Meyer et al 2011;Sultan et al 2012;), however there is currently no published literature on the intracranial MFM. A clinical trial to evaluate treatment of intracranial aneurysms using the MFM was conducted between September 2010 and June 2013.…”

“…In terms of aneurysm occlusion, the results of this study compare favorably with flow diverter data published previously (Brinjikji et al 2013;Rajpal et al 2013). The MFM is current being used successfully to treat peripheral, visceral and aortic aneurysms, (Henry et al 2008;Polydorou et al 2010;Chocron et al 2011;Ferrero et al 2011;Meyer et al 2011;Sultan et al 2012;), but these initial results show that the intracranial MFM offers a new minimally invasive treatment for intracranial aneurysms, alongside currently available flow diverters.…”